Table of Contents for Journal of Surgical Oncology. List of articles from both the latest and EarlyView issues.
4 followers 6 articles/week
Comparing cefazolin/ metronidazole,  piperacillin‐tazobactam, or c efoxitin as surgical antibiotic prophylaxis in patients undergoing pancreaticoduodenectomy: A retrospective cohort study

Abstract Background Preoperative antibiotic options for pancreaticoduodenectomy (PD) include cefoxitin (CX), piperacillin-tazobactam (PT), or combined cefazolin and metronidazole (CM). Recent studies suggest the superiority of PT over CX, but evidence for CM is unclear. Objective To explore the impact of preoperative antibiotic selection (CM vs....

Fri Apr 26, 2024 12:01
Navigating the complexity of post‐NAT therapy in breast cancer: The role of ctDNA testing

Journal of Surgical Oncology, EarlyView.

Wed Apr 24, 2024 12:57
Issue Information

Journal of Surgical Oncology, Volume 129, Issue 6, Page 1007-1011, May 2024.

Wed Apr 24, 2024 12:57
The associations of food environment with gastrointestinal cancer outcomes in the United States

Abstract Background Social conditions and dietary behaviors have been implicated in the rising burden of gastrointestinal cancers (GIC). The “food environment” reflects influences on a community level relative to food availability, nutritional assistance, and social determinants of health. Using the US Department of Agriculture-Food Environment Atlas...

Tue Apr 23, 2024 13:23
Racial disparities in disease‐specific mortality and surgical management of patients with ductal carcinoma in situ with microinvasion

Abstract Background and Objectives Given persistent racial disparities in breast cancer outcomes, this study explores racial differences in disease-specific mortality and surgical management among patients with microinvasive ductal carcinoma in situ (DCIS-MI). Methods The Surveillance, Epidemiology, and End Results Program was queried for patients...

Mon Apr 22, 2024 13:51
Modern management of the axilla

Abstract Surgical management of the axilla has evolved considerably in recent years, with a strong focus on de-escalation to minimise morbidity whilst maintaining oncological outcomes. Current trials will focus on the omission of Sentinel node biopsy in select groups of patients, while axillary lymph node dissection will be reserved for those with...

Mon Apr 22, 2024 13:51

Build your own newsfeed

Ready to give it a go?
Start a 14-day trial, no credit card required.

Create account